Page 22 - Shimadzu Journal vol.9 Issue2
P. 22

Biopharmaceutical






















































































                Fig. 5. Top left: Chromatograms of deamidated and unmodified ‘ASQDVNTAVAWYQQKPGK’ ; Top right: MS1 spectra of deamidated and un-
                modified ‘ASQDVNTAVAWYQQKPGK’ ; Middle: MS/MS fragmentation pattern for deamidated and unmodified ‘ASQDVNTAVAWYQQKPGK’
                Bottom: Zoomed MS/MS fragmentation spectra for deamidated and unmodified ‘ASQDVNTAVAWYQQKPGK’






                                                                                                                 55
                                                                                                Shimadzu Journal  vol.9  Issue2 55
   17   18   19   20   21   22   23   24   25   26   27